Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by MirrorWorldManon Sep 24, 2019 2:09pm
96 Views
Post# 30159891

RE:RE:RE:RE:RE:RE:RE:RE:Simple math

RE:RE:RE:RE:RE:RE:RE:RE:Simple mathI have not read anywhere in the NR that we are selling as a vendor an active ingredient to R+F at a certain price for a profit. Only Upfronts, Milestones and Royalties are mentioned. On the royalty side, and along similar lines , I have owned other BT’s that openly stated a 50/50 split on gross sales revenues but that was as a Pharma with exclusive rights promoting a prescription drug manufactured by a BioTech in the US. As was mentioned on the board,  there are many differences as this is a cosmetic ingredient suppled to a private MLM with non professionals selling in a different business model, so I dont think anyone really knows what revenues will be spitting out and when it will be paid to us. Nevertheless,I see it as nice way to get ‘real world’ efficacy of our skin lightener and those testimonies can be leveraged as fuel for future deals. A launch timeline would be very nice to know.
Bullboard Posts